First Time Loading...

Ensysce Biosciences Inc
NASDAQ:ENSC

Watchlist Manager
Ensysce Biosciences Inc Logo
Ensysce Biosciences Inc
NASDAQ:ENSC
Watchlist
Price: 0.59 USD -2.96% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

ENSC Price Targets Summary
Ensysce Biosciences Inc

There are no price targets for ENSC.
ENSC Lowest Forecast
Wall Street Target
Not Available
ENSC Average Forecast
Wall Street Target
Not Available
ENSC Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ensysce Biosciences Inc Competitors:
Price Targets
LEGN
Legend Biotech Corp
100% Upside
GMAB
Genmab A/S
40% Upside
PROB
Probi AB
59% Upside
C
688276
Changchun BCHT Biotechnology Co
62% Upside
LEGN
Legend Biotech Corp
100% Upside
GMAB
Genmab A/S
40% Upside
PROB
Probi AB
59% Upside
C
688276
Changchun BCHT Biotechnology Co
62% Upside
VITR
Vitrolife AB
48% Upside
IOVA
Iovance Biotherapeutics Inc
111% Upside
BCYC
Bicycle Therapeutics PLC
76% Upside
PHARM
Pharming Group NV
108% Upside

Revenue
Forecast

Revenue Estimate
Ensysce Biosciences Inc

The compound annual growth rate of Ensysce Biosciences Inc's revenue for the next 3 years is 201%.

N/A
Past Growth
201%
Estimated Growth
Estimates Accuracy
9%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ensysce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ensysce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
What are analyst estimates?

See Also

Summary
ENSC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ENSC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ENSC stock valuation using valuation multiples.
Wall Street Estimates
ENSC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ENSC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENSC's stock price target?
Not Available

ENSC doesn't have any price targets made by Wall Street professionals.

What is Ensysce Biosciences Inc's Revenue forecast?
Projected CAGR
201%

The compound annual growth rate of Ensysce Biosciences Inc's revenue for the next 3 years is 201%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.